Dr. Sundeep Kumar Upadhyaya

Dr. Sundeep Kumar Upadhyaya

Senior Consultant 

32 Years of Experience

Rheumatologist

MD, MBBS, DM

Indraprastha Apollo Hospital, New Delhi

English

Consultation Fee ₹ 2000

Book an Appointment

About Dr. Sundeep Kumar Upadhyaya

  • Dr. Sandeep Kumar Upadhyaya boasts over 32 years of experience as a distinguished Rheumatologist.
  • He is recognized for pioneering the use of Biological agents in treating various rheumatological disorders, including Rheumatoid Arthritis and Inflammatory Spondylitis.
  • He has actively contributed to advanced clinical research on new molecules and Biological agents for conditions such as Rheumatoid Arthritis, Ankylosing Spondylitis, and SLE (lupus).
  • He played a pivotal role as a team member in formulating guidelines for Rheumatoid Arthritis treatment.
  • Dr. Upadhyaya was a member of the team involved in the IRA guidelines for Rheumatoid Arthritis treatment.
  • After completing his MBBS from the University Of Allahabad in 1992, he also achieved an MD (Medicine) from the University Of Allahabad in 1995 and a DM (Clinical Immunology) from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, in 1998.
  • He is a regular contributor to CMEs, lectures, and education of other doctors in the fields of modern medicine, rheumatology, spondylitis and arthritis, lupus, and other connective tissue diseases. 
  • He is an esteemed member of professional organizations such as the Indian Rheumatology Association, Delhi Rheumatology Association, and Indian Medical Association.

Book Your Appointment With Dr. Sundeep Kumar Upadhyaya

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, University Of Allahabad, 1992
  • MD (Medicine), University Of Allahabad, 1995
  • DM (Clinical Immunology), Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 1998

Awards

  • Among the first rheumatologists in India to use Biologic agents for a variety of rheumatological disorders, including Rheumatoid Arthritis, Inflammatory Spondylitis & Ankylosing Spondylitis

Paper Published

  • Complement and cell-mediated cytotoxicity by anti-endothelial cell antibodies in Takayasu’s arteritis. Authors: Naresh Tripathi, Sundeep Kumar Upadhyaya, Nakul Sinha, Sonia Nityanand. Journal of Rheumatology, 2001 April; 28(4):805-8.
  • Methotrexate in Seronegative Spondyloarthropathy; results of a double-blind placebo-controlled drug trial. Authors: Sundeep K Upadhyaya, Amita Aggarwal, Ram Nath Misra. Journal of Indian Rheumatology Association, 2004 March; 12(1):6-10.
  • The evolving role of Biological Response Modifiers in the management of Arthritis and Spondylitis. Author: Sundeep K Upadhyaya. Apollo Medicine, 2005 June; 2(2):107-110.
  • Use of Anti-TNF alpha agents (Infliximab and Etanercept) in Rheumatoid Arthritis and Ankylosing Spondylitis: experience of a Rheumatology practice at Apollo Hospital, India. Author: Sundeep K Upadhyaya. Apollo Medicine, 2005 June; 2(2):147-9.
  • Management of Rheumatic Disease in Pregnant and nursing women. Author: Sundeep Kumar Upadhyaya. Apollo Medicine, 2006 March; 3(1):35-38.
  • Limited Wegener’s Granulomatosis: an exception to the Pulmonary- Renal syndrome; A systematic review of Three Cases and Review of the Literature. Author: Sundeep Kumar Upadhyaya. Apollo Medicine 2006 September; 3(3):307-10.
  • Immunotherapy for cancer with special reference to lung cancer. Author: Sundeep Kumar Upadhyaya. Apollo Medicine 2006 September; 3(3):277-84.
  • Limited Wegener’s Granulomatosis: an exception to the “Pulmonary-Renal Syndrome”; a systematic review of three cases and review of the literature. Author: Sundeep K Upadhyaya. Apollo Medicine September 2006;3(3):307-310.
  • Lack of clinical association with antibodies to ribosomal P protein in Indian patients with Systemic Lupus Erythematosus. Authors: Vinod Chandran, Sundeep Kumar Upadhyaya, Nigil Haroon, Amita Aggarwal, Ramnath Misra. Journal of Rheumatology, 2006 October; 33(10):1987-9
  • Pulmonary hypertension in connective tissue disease. Authors: SK Upadhyaya, A Kumar. Indian Journal of Rheumatology, 2007 September; 2(2):114-9.
  • Musculoskeletal Disease in Primary Hyperparathyroidism-Review of literature and Case report. Authors: Sundeep K Upadhyaya, Nidhi Malhotra, Harsh Rastogi, Ambrish Mittal, Uma Ravishankar, CM Malhotra. Apollo Medicine March 2009;1(6):46-50.
  • The management of neonatal lupus syndrome. Algorithms Author: Sundeep Kumar Upadhyaya. Apollo Medicine. Apollo Medicine September 2012;9(3):280-1.
  • New and Emerging Therapies for Rheumatoid Arthritis. Author: Sundeep K Upadhyaya. Apollo Medicine March 2009;1(6):51-54.
  • The management of neonatal lupus syndrome. Algorithms. Author: Sundeep K Upadhyaya. Apollo Medicine. September 2012;3(9):280-281.
  • Treatment of Early Rheumatoid Arthritis. Algorithms. Author: Sundeep Kumar Upadhyaya. Apollo Medicine. December 2012; 4(9):345-346.
  • Treatment of Established Rheumatoid Arthritis. Algorithms. Author: Sundeep Kumar Upadhyaya. Apollo Medicine. December 2012;4(9):347-348
  • Treatment of lupus nephritis in adult patients. Algorithms. Author Sundeep K Upadhyaya. Apollo Medicine. March 2013;1(10):85-86.
  • Immunology of type-I diabetes: The journey from animal models to human therapeutics. Author: Sundeep K Upadhyaya. Apollo Medicine. June 2013;2(10):105-107.
  • Rheumatic manifestations in diabetes mellitus patients. Authors: Bhowmik Meghnathi, Sundeep K Upadhyaya. Apollo Medicine. June 2013;2(10):126-133.
  • Antibodies to Tumor Necrosis Factors in the Treatment of Rheumatoid Arthritis and Spondyloarthritis: The Basic Science, Clinical Science, and Unmet Needs; Results from a Single Center. Author: Sundeep K Upadhyaya. Open Journal of Rheumatology and Autoimmune Diseases, 2014, 4, 86-92. http://dx.doi.org/10.4236/ojra.2014.42013.

Field of Expertise

  • Giant Cell Arteritis
  • Pemphigus
  • Polymyalgia Rheumatica
  • Raynaud's Syndrome

Blogs

Guide to Health and Wellness